Marco Arese Selected Research

Biomarkers (Surrogate Marker)

1/2019

High Circulating Methylated DNA Is a Negative Predictive and Prognostic Marker in Metastatic Colorectal Cancer Patients Treated With Regorafenib.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marco Arese Research Topics

Disease

7	Neoplasms (Cancer) 07/2023 - 01/2018
2	Colorectal Neoplasms (Colorectal Cancer) 09/2022 - 01/2019
1	Prostatic Neoplasms (Prostate Cancer) 07/2023
1	Neoplasm Metastasis (Metastasis) 07/2023
1	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 09/2022
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022
1	Vascular Diseases (Vascular Disease) 01/2018
1	Vascular Remodeling 07/2012
1	Pathologic Neovascularization 01/2011
1	Autistic Disorder (Autism) 02/2010
1	Intellectual Disability (Idiocy) 02/2010

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 11/2022 - 01/2018
3	neuroligin 1IBA 09/2022 - 07/2012
2	Neurotransmitter Agents (Neurotransmitter)IBA 11/2022 - 03/2018
1	Nucleotide AptamersIBA 07/2023
1	AndrogensIBA 07/2023
1	AntigensIBA 07/2023
1	CateninsIBA 09/2022
1	Nerve Growth Factors (Neurotrophins)IBA 01/2022
1	Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA 01/2022
1	LigandsIBA 11/2021
1	regorafenibIBA 01/2019
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	DNA (Deoxyribonucleic Acid)IBA 01/2019
1	neuroligin 2IBA 01/2018
1	Semaphorins (Semaphorin)IBA 01/2011
1	NeuroliginsIBA 02/2010

Therapy/Procedure

2	Therapeutics 03/2018 - 01/2018